+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptic Ulcer Treatment Drugs Market - Global Forecast 2025-2030- Product Image
Peptic Ulcer Treatment Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Peptic Ulcer Treatment Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129674
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The peptic ulcer treatment drugs market is undergoing a significant transition, with rapid advancements transforming both therapeutic strategies and supply chain dynamics. Senior executives navigating this space require clear, actionable intelligence to make informed decisions, manage risk, and identify growth opportunities.

Market Snapshot: Peptic Ulcer Treatment Drugs

The peptic ulcer treatment drugs market is experiencing dynamic evolution, spurred by breakthroughs in pharmacotherapy, shifting regulatory landscapes, and innovation in patient care. With a robust market size and an attractive CAGR, this sector continues to attract substantial investment and attention from pharmaceutical companies. The competitive landscape is becoming more intricate as leading players respond to diversified patient needs, regulatory challenges, and disruptive forces such as digital health and changing global supply flows.

Scope & Segmentation

This comprehensive report dissects the peptic ulcer treatment drugs market across all critical dimensions, offering a robust foundation for strategic analysis. The study's segmentation scope includes:

  • Drug Class: Antibiotics (such as amoxicillin, clarithromycin, metronidazole), H2 receptor antagonists (cimetidine, famotidine, nizatidine, ranitidine), mucosal protectants, and proton pump inhibitors (including esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole).
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacies each play distinct roles in dispensing and patient support.
  • Dosage Form: Tablets, capsules, powders, and suspensions optimized for different patient cohorts and care settings.
  • End User: Clinics, home care providers, and hospitals, each with specific needs across acute and chronic treatment pathways.
  • Product Type: Over-the-counter formulations and prescription medications tailored to the severity and recurrence of peptic ulcers.
  • Regional Focus: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), and Asia-Pacific (spanning China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Competitors: AstraZeneca plc, Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline plc, Novartis AG, Bayer AG, Boehringer Ingelheim International GmbH.

Modern technologies such as biomarker-driven profiling, advanced polymer-based protectants, and digital health monitoring are referenced throughout the evaluation to guide segment strategy.

Key Takeaways for Senior Decision-Makers

  • Innovative therapies are redefining standards, with next-generation proton pump inhibitors and advanced antibiotic regimens supporting more personalized peptic ulcer management based on patient-specific risk profiles.
  • Digital health platforms and remote monitoring solutions are enhancing patient adherence and outcomes, especially as outpatient and home care become more prominent.
  • Strategic partnerships between pharma, biotech, and contract manufacturing organizations are accelerating product development and bolstering supply chain resilience.
  • Regional growth varies: North America is driven by reimbursement strength, EMEA by diverse regulatory and pricing environments, and Asia-Pacific by rapid urbanization and digital adoption.
  • Tighter regulatory oversight of prescription drugs, alongside broader OTC options for mild cases, is shifting the competitive landscape for product types and dosage forms.

Tariff Impact on Supply Chains and Pricing

Upcoming United States tariffs on pharmaceutical raw materials and active ingredients in 2025 will introduce new complexities in sourcing and pricing. Market participants face increased procurement costs and must adapt by diversifying supplier bases, renegotiating contract terms, and leveraging scenario planning to protect margins and maintain patient access.

Methodology & Data Sources

This report employs a rigorous combination of primary interviews with industry stakeholders and secondary research spanning regulatory documents, clinical trials, and market white papers. Quantitative analyses assess price shifts and adoption patterns; qualitative inputs enrich understanding of market drivers and emerging innovation. Panel reviews and triangulation of findings ensure accuracy and reliability.

Why This Report Matters

  • Unpack actionable, segment-specific insights to align drug development and commercialization strategies with evolving therapeutic and regulatory trends.
  • Benchmark best practices in collaboration, technology adoption, and supply chain adaptation to navigate challenges such as tariffs and rapid market changes.
  • Equip executive leadership with a clear evidence-based roadmap for optimizing portfolios, driving operational efficiency, and expanding global presence.

Conclusion

Effective navigation of the peptic ulcer treatment drugs market requires adaptive strategies, robust evidence generation, and a commitment to collaboration across the value chain. Leverage the insights presented to strengthen your organization’s position and deliver sustainable value in a rapidly evolving therapeutic landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of acid-suppressive therapy alternatives to PPIs among high-risk patients
5.2. Increased R&D investment in novel Helicobacter pylori eradication therapies with reduced resistance rates
5.3. Emergence of sustained release gastro-retentive formulations to improve peptic ulcer healing compliance
5.4. Expanding usage of gut microbiome modulation as adjunct therapy in peptic ulcer management
5.5. Surge in generic omeprazole biosimilar approvals driving competitive pricing pressure in core markets
5.6. Regulatory approval of novel mucosal protective agents demonstrating improved barrier healing efficacy
5.7. Integration of digital health platforms to monitor patient adherence and outcomes in ulcer treatment
5.8. Rising demand for combination therapies targeting acid suppression and mucosal protection in high-risk cohorts
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peptic Ulcer Treatment Drugs Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Amoxicillin
8.2.2. Clarithromycin
8.2.3. Metronidazole
8.3. H2 Receptor Antagonists
8.3.1. Cimetidine
8.3.2. Famotidine
8.3.3. Nizatidine
8.3.4. Ranitidine
8.4. Mucosal Protectants
8.5. Proton Pump Inhibitors
8.5.1. Esomeprazole
8.5.2. Lansoprazole
8.5.3. Omeprazole
8.5.4. Pantoprazole
8.5.5. Rabeprazole
9. Peptic Ulcer Treatment Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Peptic Ulcer Treatment Drugs Market, by Dosage Form
10.1. Introduction
10.2. Capsules
10.3. Powders
10.4. Suspensions
10.5. Tablets
11. Peptic Ulcer Treatment Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Peptic Ulcer Treatment Drugs Market, by Product Type
12.1. Introduction
12.2. Over The Counter
12.3. Prescription
13. Americas Peptic Ulcer Treatment Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Peptic Ulcer Treatment Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Peptic Ulcer Treatment Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AstraZeneca plc
16.3.2. Takeda Pharmaceutical Company Limited
16.3.3. Pfizer Inc.
16.3.4. Johnson & Johnson
16.3.5. Merck & Co., Inc.
16.3.6. Sanofi S.A.
16.3.7. GlaxoSmithKline plc
16.3.8. Novartis AG
16.3.9. Bayer AG
16.3.10. Boehringer Ingelheim International GmbH
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. PEPTIC ULCER TREATMENT DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PEPTIC ULCER TREATMENT DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PEPTIC ULCER TREATMENT DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PEPTIC ULCER TREATMENT DRUGS MARKET: RESEARCHAI
FIGURE 26. PEPTIC ULCER TREATMENT DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. PEPTIC ULCER TREATMENT DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. PEPTIC ULCER TREATMENT DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PEPTIC ULCER TREATMENT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY METRONIDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY METRONIDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CIMETIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY NIZATIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RANITIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RANITIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY MUCOSAL PROTECTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY MUCOSAL PROTECTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY LANSOPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY LANSOPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PANTOPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PANTOPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 118. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 119. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 120. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 121. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 122. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 123. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 124. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 125. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 144. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 145. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 218. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 219. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 226. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 227. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 234. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 235. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 266. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 267. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 268. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 269. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 270. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 271. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 282. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 283. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 284. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 285. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 286. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 287. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 290. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 291. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. SPAIN PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES PEPTIC ULCER TREATMENT DRUGS MARKET SIZE, BY DO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peptic Ulcer Treatment Drugs Market report include:
  • AstraZeneca plc
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Novartis AG
  • Bayer AG
  • Boehringer Ingelheim International GmbH

Related Topics

Related Reports

Peptic Ulcer Medication Market - Global Forecast 2025-2030 - Product Image

Peptic Ulcer Medication Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Peptic Ulcers Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Peptic Ulcers Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 150 Pages
  • Global
From
Pirenzepine Hydrochloride Market - Global Forecast 2025-2030 - Product Image

Pirenzepine Hydrochloride Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
H2 Receptor Antagonist Global Market Report 2025 - Product Image

H2 Receptor Antagonist Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.